sore
throat
account
patient
visit
officebas
primari
care
practition
hospit
outpati
depart
emerg
depart
unit
state
data
nation
medic
care
survey
indic
approxim
million
annual
visit
children
visit
adult
thu
familiar
principl
diagnosi
manag
disord
essenti
primari
care
physician
see
patient
age
hallmark
acut
pharyng
sore
throat
vari
degre
clinic
sever
pharyng
erythema
fever
case
pharyng
viral
origin
except
ill
benign
selflimit
larg
proport
case
pharyng
associ
rhinoviru
coronaviru
cold
influenza
import
caus
bacteri
pharyng
betahemolyt
group
streptococcu
streptococcu
pyogen
ga
uncommon
rare
type
pharyng
treatment
also
requir
avail
recogn
microbi
caus
pharyng
list
tabl
show
syndrom
respiratori
ill
caus
variou
agent
still
possibl
determin
caus
sizabl
proport
case
major
task
primari
care
physician
identifi
patient
acut
pharyng
requir
specif
antimicrobi
therapi
avoid
unnecessari
potenti
deleteri
treatment
great
major
suffer
benign
selflimit
usual
viral
infect
case
distinct
made
easili
attent
epidemiolog
set
histori
physic
find
augment
perform
simpl
readili
avail
laboratori
studi
result
epidemiolog
investig
influenc
season
year
age
popul
sever
ill
diagnost
method
use
detect
case
case
pharyng
occur
colder
month
year
respiratori
diseas
season
viral
agent
rhinovirus
tend
annual
period
peak
preval
fall
spring
coronavirus
found
often
winter
influenza
appear
epidem
unit
state
usual
occur
decemb
april
militari
recruit
adenovirus
caus
syndrom
acut
respiratori
diseas
colder
month
civilian
acut
respiratori
diseas
occur
winter
epidem
pharyngoconjunctiv
fever
occur
summer
streptococc
pharyng
occur
respiratori
diseas
season
peak
rate
infect
winter
earli
spring
spread
among
famili
member
home
promin
featur
epidemiolog
behavior
agent
children
major
reservoir
infect
shown
tabl
number
bacteria
may
caus
acut
pharyng
rare
unusu
caus
syndrom
moreov
benefit
antimicrobi
therapi
agent
ie
arcanobacterium
haemolyticum
nongroup
beta
hemolyt
streptococci
unclear
thu
ga
commonli
occur
caus
sore
throat
antimicrobi
therapi
definit
indic
ga
estim
caus
case
acut
tonsillopharyng
occur
cooler
month
year
schoolag
children
approxim
case
adult
consider
variabl
studi
studi
nation
howev
approxim
children
adult
sore
throat
receiv
antimicrobi
agent
substanti
proport
receiv
antimicrobi
agent
recommend
treatment
choic
ga
pharyng
follow
discuss
provid
recommend
unnecessari
andor
inappropri
therapi
may
minim
characterist
clinic
find
summar
tabl
presenc
mark
odynophagia
exud
tonsillopharyng
fig
anterior
cervic
aden
fever
leukocytosi
highli
suggest
ga
pharyng
none
sign
symptom
list
tabl
specif
strep
throat
howev
moreov
patient
vari
wide
sever
symptom
mani
case
milder
nonexud
approxim
half
children
present
sore
throat
posit
throat
cultur
tonsillar
pharyng
exud
patient
tonsillectomi
may
milder
symptom
children
less
year
age
may
coryza
crust
nare
exud
pharyng
caus
ga
rare
age
group
hand
presenc
cough
coryza
children
older
year
hoars
diarrhea
conjunct
andor
anterior
stomat
highli
indic
viral
rather
streptococc
infect
scarlet
fever
result
infect
streptococc
strain
elabor
streptococc
pyrogen
exotoxin
erythrogen
toxin
patient
immun
although
diseas
usual
associ
pharyng
infect
may
follow
streptococc
infect
site
wound
infect
puerper
sepsi
nowaday
clinic
syndrom
similar
respect
associ
nontoxigen
strain
save
scarlatin
rash
latter
must
differenti
viral
exanthem
drug
erupt
staphylococc
streptococc
toxic
shock
syndrom
kawasaki
diseas
confront
patient
acut
pharyng
clinician
must
decid
whether
likelihood
ga
infect
high
enough
warrant
confirmatori
diagnost
test
patient
lack
suggest
clinic
epidemiolog
find
manifest
sign
symptom
indic
viral
pharyng
see
tabl
need
test
treat
antimicrobi
agent
attempt
made
incorpor
clinic
epidemiolog
featur
acut
pharyng
score
system
attempt
predict
probabl
particular
ill
caus
ga
clinic
score
system
help
identifi
patient
low
risk
streptococc
infect
test
usual
unnecessari
select
use
diagnost
studi
ga
increas
proport
posit
test
result
also
percentag
patient
posit
test
truli
infect
rather
mere
streptococc
carrier
sign
symptom
streptococc
nonstreptococc
pharyng
overlap
broadli
howev
allow
requisit
diagnost
precis
clinic
ground
alon
although
suggest
otherwis
empir
antimicrobi
treatment
base
clinic
epidemiolog
ground
alon
found
suboptim
cost
effect
prospect
analys
therefor
clinician
unabl
rule
strep
throat
clinic
epidemiolog
ground
test
requir
see
later
discuss
properli
perform
interpret
throat
cultur
gold
standard
diagnosi
ga
pharyng
sensit
higher
judg
studi
employ
duplic
throat
cultur
obtain
definit
result
throat
cultur
take
hour
minor
patient
sever
ill
toxic
present
clinic
epidemiolog
evid
lead
high
index
suspicion
oral
antimicrobi
therapi
may
initi
await
result
throat
cultur
oral
therapi
prescrib
throat
cultur
serv
guid
necess
complet
full
antimicrobi
cours
altern
recal
patient
inject
penicillin
g
benzathin
earli
initi
antimicrobi
therapi
result
faster
resolut
sign
symptom
two
fact
kept
mind
first
ga
pharyng
usual
selflimit
diseas
fever
constitut
symptom
markedli
diminish
within
day
onset
even
without
antimicrobi
therapi
thu
antimicrobi
therapi
initi
within
first
hour
onset
hasten
symptomat
improv
modestli
second
shown
therapi
postpon
safe
day
onset
symptom
still
prevent
occurr
major
nonsuppur
sequela
acut
rheumat
fever
issu
allud
previou
discuss
may
obviat
part
use
rapid
antigen
detect
test
radt
confirm
presenc
ga
carbohydr
antigen
throat
swab
matter
minut
current
avail
commerci
test
kit
yield
result
highli
specif
presenc
ga
thu
posit
radt
consid
equival
posit
throat
cultur
therapi
may
initi
without
microbiolog
confirm
unfortun
sensit
test
rang
compar
blood
agar
plate
cultur
reason
necessari
back
neg
radt
convent
throat
cultur
one
possibl
except
need
backup
relat
adult
preval
ga
pharyng
rel
low
risk
first
attack
acut
rheumat
fever
north
america
minim
posit
radt
throat
cultur
differenti
presenc
acut
streptococc
infect
chronic
ga
carriag
appropri
clinic
set
howev
posit
test
consid
confirmatori
strep
throat
followup
throat
cultur
indic
routin
asymptomat
patient
receiv
complet
cours
therapi
ga
pharyng
patient
streptococc
carrier
except
includ
patient
histori
rheumat
fever
patient
develop
acut
pharyng
outbreak
either
acut
rheumat
fever
poststreptococc
acut
glomerulonephr
outbreak
ga
pharyng
close
semiclos
commun
followup
throat
cultur
also
may
indic
pingpong
spread
ga
occur
within
famili
treatment
ga
pharyng
recommend
prevent
acut
rheumat
fever
prevent
suppur
complic
shorten
clinic
cours
although
modestli
reduc
transmiss
infect
famili
school
unit
definit
evid
therapi
prevent
acut
glomerulonephr
number
antibiot
shown
effect
therapi
ga
pharyng
includ
penicillin
congen
ampicillin
amoxicillin
numer
cephalosporin
macrolid
clindamycin
penicillin
howev
remain
treatment
choic
proven
efficaci
safeti
narrow
spectrum
low
cost
amoxicillin
often
use
place
oral
penicillin
v
young
children
efficaci
appear
equal
choic
relat
primarili
superior
palat
suspens
erythromycin
suitabl
altern
patient
allerg
penicillin
although
increas
ga
resist
agent
report
certain
local
area
unit
state
firstgener
cephalosporin
also
accept
penicillinallerg
patient
manifest
immediatetyp
hypersensit
betalactam
antibiot
debat
regard
rel
efficaci
cephalosporin
visavi
penicillin
erad
ga
pharynx
util
shorter
cours
certain
antimicrobi
agent
treat
strep
throat
discuss
topic
reader
refer
infecti
diseas
societi
america
idsa
practic
guidelin
penicillin
howev
remain
prefer
therapi
accord
guidelin
publish
american
heart
associ
american
academi
pediatr
idsa
tabl
idsa
guidelin
also
offer
guidanc
manag
patient
recurr
episod
cultureor
radtposit
acut
ga
pharyng
preliminari
investig
demonstr
oncedaili
amoxicillin
therapi
effect
treatment
group
beta
hemolyt
streptococcu
pharyng
care
studi
feder
colleagu
randomli
assign
children
receiv
amoxicillin
mg
daili
penicillin
v
mg
three
time
daili
complianc
monitor
urin
antimicrobi
activ
serotyp
perform
distinguish
treatment
failur
new
acquisit
two
regimen
although
shorter
cours
azithromycin
cephalosporin
report
effect
treat
group
streptococc
upper
respiratori
tract
infect
evid
suffici
recommend
shorter
cours
routin
therapi
time
b
amoxicillin
often
use
place
oral
penicillin
v
young
children
efficaci
seem
equal
choic
relat
primarili
accept
tast
suspens
c
patient
weigh
kg
dose
determin
basi
benzathin
compon
exampl
mixtur
u
benzathin
penicillin
g
u
procain
penicillin
g
contain
less
benzathin
penicillin
g
recommend
treatment
adolesc
adult
e
avail
stearat
ethyl
succin
estol
base
cholestat
hepat
rare
may
occur
patient
primarili
adult
receiv
erythromycin
estol
incid
greater
among
pregnant
women
receiv
formul
f
agent
use
treat
patient
immediatetyp
hypersensit
betalactam
antibiot
equal
effect
erad
ga
pharynx
addit
investig
confirm
result
oncedaili
amoxicillin
therapi
low
cost
rel
narrow
spectrum
could
becom
altern
regimen
treatment
group
betahemolyt
streptococc
pharyng
suppur
complic
ga
pharyng
includ
peritonsillar
infect
retropharyng
abscess
cervic
lymphaden
mastoid
lemierr
syndrom
sinus
otiti
media
complic
becom
rel
rare
sinc
advent
effect
chemotherapi
peritonsillar
infect
may
take
form
cellul
abscess
quinsi
common
form
deep
oropharyng
infect
although
peritonsillar
abscess
may
occur
complic
ga
pharyng
abscess
frequent
contain
varieti
oral
flora
includ
anaerob
without
ga
occur
frequent
adolesc
adult
young
children
pharyng
pain
usual
sever
dysphagia
common
examin
inflamm
swell
peritonsillar
area
medial
displac
tonsil
patient
speak
hot
potato
voic
trismu
may
present
peritonsillar
cellul
may
treat
antibiot
alon
abscess
requir
drainag
direct
aspir
incis
drainag
given
polymicrobi
natur
infect
parenter
antibiot
clindamycin
penicillin
metronidazol
ampicillinsulbactam
frequent
employ
superior
penicillin
demonstr
definit
howev
lemierr
syndrom
postangin
septicemia
caus
acut
oropharyng
infect
secondari
septic
thrombophleb
intern
jugular
vein
often
bacterem
spread
lung
elsewher
common
caus
organ
fusobacterium
necrophorum
clinic
find
includ
acut
present
fever
swell
tender
angl
jaw
neck
rigid
dysphagia
dysphonia
occur
peritonsillar
area
inflam
earli
diseas
emerg
medic
treatment
intraven
antibiot
clindamycin
penicillin
metronidazol
ampicillinsulbactam
usual
suffici
time
ligat
intern
jugular
vein
requir
acut
rheumat
fever
poststreptococc
acut
glomerulonephr
delay
nonsuppur
sequela
ga
pharyng
although
former
occur
ga
upper
respiratori
infect
latter
may
occur
infect
throat
skin
streptococc
pyoderma
discuss
entiti
beyond
scope
articl
nongroup
betahemolyt
streptococci
classifi
biochem
speci
clinic
purpos
howev
usual
identifi
express
lancefield
cellwal
antigen
certain
strain
clearli
capabl
caus
acut
pharyng
ingest
high
inocula
streptococci
serogroup
g
link
commonsourc
outbreak
pharyng
usual
relat
food
product
one
unusu
speci
group
c
organ
streptococcu
equi
subspeci
zooepidemicu
given
rise
commonsourc
epidem
pharyng
usual
caus
consumpt
unpasteur
dairi
product
sever
outbreak
associ
poststreptococc
acut
glomerulonephr
group
c
g
streptococci
common
commens
human
pharynx
form
larg
coloni
similar
ga
belong
speci
streptococcu
dysgalactia
subspeci
equisimili
physician
back
neg
radt
throat
cultur
identifi
organ
extent
caus
sporad
occur
episod
true
acut
pharyng
unclear
sever
care
studi
suggest
group
c
streptococci
may
caus
episod
pharyng
mimic
ga
infect
moreov
communitywid
outbreak
group
g
streptococc
pharyng
occur
connecticut
winter
difficulti
differenti
benign
colon
true
infect
group
c
g
streptococci
benefit
antimicrobi
therapi
sporad
occur
case
unknown
therapi
elect
agent
list
tabl
would
appropri
probabl
shorter
durat
nongroup
streptococci
never
shown
caus
acut
rheumat
fever
arcanobacterium
haemolyticum
arcanobacterium
formerli
corynebacterium
haemolyticum
gramposit
bacillu
rel
uncommon
caus
acut
pharyng
tonsil
symptomat
infect
organ
close
mimic
acut
streptococc
pharyng
rare
haemolyticum
produc
membran
pharyng
confus
diphtheria
two
featur
pharyng
infect
organ
notabl
predilect
adolesc
young
adult
frequent
provok
gener
rash
may
resembl
scarlet
fever
organ
detect
readili
humanthan
sheepblood
agar
plate
thu
may
identifi
routin
throat
cultur
thu
clinician
suspect
haemolyticum
infect
teenag
young
adult
acut
pharyng
scarlatiniform
rash
neg
cultur
radt
ga
antimicrobi
therapi
patient
haemolyticum
pharyng
elect
macrolid
altern
betalactam
antimicrobi
agent
may
prescrib
neisseria
gonorrhoea
neisseria
gonorrhoea
uncommon
sexual
transmit
caus
acut
pharyng
seen
person
practic
recept
oral
sex
risk
acquisit
mean
highest
men
sex
men
msm
rate
pharyng
gonorrhea
msm
report
high
recent
studi
san
francisco
found
n
gonorrhoea
pharynx
msm
conclud
pharynx
common
site
infect
popul
high
preval
unit
state
center
diseas
control
prevent
cdc
guidelin
sexual
transmit
diseas
recommend
yearli
pharyng
test
n
gonorrhoea
msm
receiv
oral
intercours
although
presenc
gonorrhea
pharynx
common
occurr
symptomat
pharyng
rare
abovement
san
francisco
studi
associ
presenc
n
gonorrhoea
pharyng
symptom
symptomat
oral
infect
occur
pharyng
tonsil
common
manifest
sore
throat
erythemat
pharynx
bilater
tonsillar
enlarg
time
grayishyellowish
exud
occasion
cervic
lymphadenopathi
report
gingiv
glossiti
also
describ
diagnosi
confirm
cultur
thayermartin
medium
current
ceftriaxon
mg
singular
intramuscular
dose
cdc
recommend
therapi
uncompl
pharyng
gonorrhea
concomit
therapi
chlamydia
recommend
infect
rule
corynebacterium
diphtheria
pharyng
diphtheria
caus
corynebacterium
diphtheria
human
reservoir
organ
asymptomat
carrier
account
popul
endem
area
transmiss
occur
respiratori
secret
although
diphtheria
becom
extrem
rare
unit
state
develop
countri
effect
childhood
immun
program
reason
primari
care
physician
infecti
diseas
specialist
familiar
diseas
first
indigen
case
unit
state
last
year
unimmun
underimmun
individu
lower
socioeconom
group
second
larg
proport
adult
north
america
western
europ
lack
protect
serum
level
antitox
immun
risk
acquir
infect
travel
endem
area
fatal
case
occur
pennsylvania
resid
travel
haiti
assist
build
church
epidem
diphtheria
involv
thousand
case
occur
among
resid
newli
independ
countri
former
soviet
union
third
earli
diagnosi
treatment
import
predictor
ultim
prognosi
respiratori
diphtheria
typic
caus
toxinproduc
toxigen
strain
c
diphtheria
rare
toxigen
strain
corynebacterium
ulceran
main
pathogen
factor
exotoxin
capabl
produc
sever
local
reaction
respiratori
mucosa
format
dens
necrot
coagulum
pseudomembran
pseudomembran
lead
airway
obstruct
result
suffoc
death
toxin
also
respons
sever
cardiac
neurolog
complic
incub
period
day
follow
malais
sore
throat
lowgrad
fever
notabl
physic
find
grayishbrown
diphtherit
pseudomembran
may
involv
one
tonsil
may
extend
wide
involv
nare
uvula
soft
palat
pharynx
larynx
tracheobronchi
tree
firmli
adher
mucosa
remov
provok
bleed
sever
case
swell
soft
tissu
neck
bull
neck
cervic
adenopathi
profound
malais
prostrat
stridor
cardiac
complic
manifest
myocard
cardiac
dysfunct
occur
case
usual
pharyng
manifest
improv
neurolog
complic
occur
also
relat
directli
sever
primari
infect
immun
histori
time
onset
symptom
institut
treatment
diagnosi
diphtheria
requir
high
index
suspicion
specif
laboratori
techniqu
diagnosi
suspect
epidemiolog
ground
presenc
pharyng
pseudomembran
especi
extend
uvula
soft
palat
bleed
dislodg
plate
loeffler
tindal
select
media
identifi
black
coloni
metachromat
granul
definit
diagnosi
requir
demonstr
toxin
product
immunoprecipit
polymeras
chain
reaction
pcr
immunochromatographi
success
treatment
invers
relat
durat
diseas
therapi
start
diagnosi
seem
like
clinic
ground
await
laboratori
confirm
treatment
diphtheria
includ
diphtheria
antitoxin
antibiot
equin
diphtheria
antitoxin
avail
nation
immun
program
cdc
therapeut
dose
mode
administr
recommend
american
academi
pediatr
accord
durat
extens
diseas
antibiot
effect
decreas
local
infect
decreas
toxin
product
decreas
spread
intramuscular
penicillin
g
switch
oral
penicillin
v
patient
abl
swallow
erythromycin
antibiot
choic
respiratori
diphtheria
contrast
cutan
diphtheria
induc
protect
immun
diphtheria
toxoid
administ
patient
convalesc
prevent
transmiss
crucial
accomplish
strict
isol
close
contact
cultur
start
prophylact
antibiot
await
cultur
result
fulli
immun
receiv
diptheria
toxoid
penicillin
erythromycin
efficaci
erad
carrier
state
erythromycin
shown
superior
report
c
ulceran
anim
pathogen
caus
bovin
mastiti
transmit
human
consumpt
raw
milk
produc
diphtherit
toxin
clinic
diseas
undistinguish
c
diphtheria
mycoplasma
pneumonia
chlamydophila
pneumonia
known
caus
lower
respiratori
tract
infect
also
found
throat
patient
symptomat
pharyng
asymptomat
carrier
although
agent
probabl
caus
case
acut
pharyng
either
primari
pathogen
copathogen
frequenc
occur
still
unclear
pharyng
manifest
describ
includ
erythema
tonsillar
enlarg
less
often
exud
cervic
lymphadenopathi
recent
italian
studi
children
acut
tonsillopharyng
test
pneumonia
c
pneumonia
acuteand
convalescentphas
titer
pcr
nasopharyng
aspir
thirtysix
children
serolog
confirm
acut
pneumonia
infect
serolog
confirm
c
pneumonia
infect
five
latter
also
posit
nasopharyng
pcr
organ
children
assign
randomli
receiv
azithromycin
plu
symptomat
treatment
symptomat
treatment
alon
follow
month
short
term
differ
outcom
children
without
atyp
infect
significantli
decreas
rate
recurr
upper
lower
respiratori
infect
occur
patient
atyp
infect
random
azithromycin
howev
result
requir
confirm
infecti
mononucleosi
clinic
manifest
infecti
mononucleosi
im
glandular
fever
caus
epsteinbarr
viru
ebv
viru
present
oropharyng
secret
patient
im
spread
persontoperson
contact
infect
ebv
frequent
childhood
usual
asymptomat
clinic
manifest
common
infect
acquir
adolesc
young
adulthood
thu
case
im
occur
age
year
symptom
develop
incub
period
week
follow
prodrom
period
chill
sweat
feverish
malais
diseas
present
classic
triad
sever
sore
throat
accompani
fever
high
c
c
lymphadenopathi
pharyng
associ
tonsil
occur
patient
tonsillar
exud
present
approxim
one
third
case
palat
petechia
may
also
present
lymphadenopathi
bilater
particularli
posterior
cervic
involv
axillari
inguin
area
patient
rash
variabl
morpholog
administr
ampicillin
amoxicillin
provok
prurit
maculopapular
erupt
patient
hepatomegali
present
patient
im
splenomegali
occur
almost
half
patient
classic
clinic
present
im
occur
children
young
adult
older
adult
may
exhibit
pharyng
lymphadenopathi
diseas
manifest
fever
promin
hepat
abnorm
typhoid
present
ebv
infect
complic
varieti
neurolog
oncolog
condit
beyond
scope
articl
hematolog
find
includ
leukocytosi
lymphocytosi
thrombocytopenia
usual
mild
occasion
may
sever
lymphocytosi
usual
found
present
peak
week
onset
diseas
presenc
atyp
lymphocyt
peripher
blood
one
characterist
featur
im
support
diagnosi
differenti
diagnosi
initi
present
includ
ga
pharyng
respiratori
viral
infect
see
tabl
cytomegaloviru
infect
suggest
epidemiolog
histori
acut
retrovir
syndrom
see
later
discuss
rare
entiti
toxoplasmosi
hepat
human
herpesviru
rubella
must
consid
case
diagnosi
readili
confirm
suspect
initi
diagnost
studi
includ
throat
cultur
radt
ga
serolog
test
presenc
heterophil
antibodi
latter
antibodi
direct
antigen
erythrocyt
differ
anim
speci
present
approxim
affect
adolesc
adult
within
first
week
ill
may
persist
year
spot
slide
test
use
hors
purifi
bovin
erythrocyt
allow
rapid
screen
commerci
avail
combin
compat
clinic
present
posit
rapid
test
heterophil
antibodi
consid
diagnost
im
falseneg
test
occur
patient
howev
especi
children
older
adult
earli
stage
diseas
approxim
patient
classic
mononucleosi
syndrom
neg
test
heterophil
antibodi
patient
ebvspecif
antibodi
assay
use
gener
clinic
purpos
igm
antibodi
viral
capsid
antigen
test
present
clinic
present
persist
week
antibodi
epsteinbarr
nuclear
antigen
first
appear
week
onset
persist
life
mani
patient
heterophileneg
im
found
aforement
test
infect
ebv
major
remaind
serolog
studi
confirm
infect
cytomegaloviru
produc
syndrom
close
mimick
induc
ebv
im
predominantli
selflimit
diseas
studi
fail
detect
benefit
use
antivir
agent
symptom
resolv
within
week
onset
physic
activ
tailor
patient
toler
risk
splenic
ruptur
contact
sport
heavi
lift
avoid
spleen
return
normal
size
usual
approxim
week
use
corticosteroid
studi
clinic
trial
clear
benefit
demonstr
steroid
howev
may
use
manag
sever
complic
airway
obstruct
hemolyt
anemia
sever
thrombocytopenia
aplast
anemia
within
day
week
initi
infect
hiv
type
patient
develop
constel
symptom
known
acut
retrovir
syndrom
fever
sore
throat
lymphadenopathi
maculopapular
rash
myalgia
arthralgia
mucocutan
ulcer
landmark
syndrom
nonexud
pharyng
present
patient
oropharyng
find
includ
ulcer
thrush
oral
ulcer
occur
patient
appear
first
day
ill
last
approxim
week
distribut
usual
inner
lip
floor
mouth
tonsil
soft
palat
uvula
also
involv
fever
occur
almost
patient
acut
retrovir
syndrom
usual
high
lymphadenopathi
occur
patient
nontend
usual
develop
week
ill
involv
cervic
axillari
inguin
region
skin
rash
occur
patient
usual
maculopapular
dissemin
almost
invari
involv
neck
upper
trunk
rash
usual
spare
distal
extrem
although
palm
sole
affect
clinic
find
fever
pharyng
lymphadenopathi
may
simul
im
atyp
lymphocytosi
although
infrequ
also
could
lead
misdiagnosi
mononucleosi
acut
retrovir
syndrom
differenti
mononucleosi
howev
acut
onset
absenc
exud
promin
tonsillar
hypertrophi
frequent
occurr
rash
rare
mononucleosi
except
treatment
ampicillin
amoxicillin
presenc
oral
ulcer
tabl
import
clinician
recogn
elisa
commonli
use
diagnos
infect
neg
first
week
infect
therefor
use
set
test
antigen
prefer
quantit
assay
plasma
hiv
rna
branch
chain
dna
pcr
perform
viral
load
anticip
high
acut
phase
infect
hiv
antibodi
test
alway
perform
later
time
confirm
diagnosi
treatment
acut
retrovir
syndrom
highli
activ
antiretrovir
medic
controversi
current
recommend
consid
use
antiretrovir
medic
set
acut
hiv
infect
option
potenti
benefit
antiretrovir
therapi
acut
hiv
would
decreas
sever
acut
diseas
decreas
viral
replic
studi
demonstr
improv
laboratori
marker
diseas
progress
highli
activ
antiretrovir
therapi
use
acut
hiv
infect
result
would
suggest
decreas
progress
transmiss
diseas
treat
acut
hiv
infect
howev
also
potenti
risk
includ
known
side
effect
medic
possibl
develop
resist
advers
effect
qualiti
life
patient
clinician
elect
start
antiretrovir
medic
goal
suppress
viral
replic
wherea
respiratori
virus
caus
symptom
indistinguish
common
cold
acut
pharyng
virus
may
produc
distinct
clinic
syndrom
adenoviru
adenoviru
common
caus
viral
pharyng
manifest
clinic
upper
respiratori
infect
fever
cough
rhinorrhea
sore
throat
usual
pronounc
common
cold
pharynx
erythemat
frequent
may
exud
mimic
streptococc
pharyng
distinct
syndrom
associ
adenoviru
infect
children
pharyngoconjunctiv
fever
diseas
occur
outbreak
character
conjunct
pharyng
rhiniti
cervic
aden
high
fever
although
adenovir
infect
commonli
occur
winter
month
pharyngoconjuntiv
fever
implic
outbreak
summer
camp
associ
contamin
swim
pool
pond
sever
type
adenoviru
also
implic
outbreak
influenzalik
ill
sore
throat
rhinorrhea
tracheobronch
known
acut
respiratori
diseas
armi
recruit
infect
self
limit
symptomat
treatment
alon
recommend
coxsacki
viru
enterovir
infect
occur
summer
fall
present
febril
ill
sore
throat
cough
coryza
distinct
manifest
enterovir
infect
herpangina
handfootandmouth
diseas
herpangina
often
caus
coxsacki
frequent
infant
young
children
usual
present
acut
fever
sore
throat
odynophagia
diffus
pharyng
erythema
vesicular
enanthem
headach
vomit
preced
symptom
oral
lesion
consist
graywhit
papulovesicl
progress
ulcer
erythemat
base
may
present
soft
palat
uvula
anterior
tonsillar
pillar
moder
pain
usual
number
less
dozen
handfootandmouth
diseas
also
caus
coxsacki
character
febril
vesicular
stomat
associ
exanthema
oral
find
includ
small
pain
vesicl
buccal
mucosa
tongu
coalesc
form
ulcer
bulla
lesion
similar
seen
herpangina
associ
peripher
rash
involv
hand
feet
extend
proxim
coxsacki
diseas
self
limit
treatment
symptomat
herp
simplex
viru
sever
studi
document
primari
human
herp
simplex
hsv
type
infect
caus
pharyng
colleg
student
occasion
caus
similar
ill
consequ
oralgenit
contact
form
pharyng
repres
primari
infect
immunocompet
patient
occur
reactiv
latent
viru
immunocompromis
host
although
characterist
present
consist
small
vesicl
ulcer
posterior
pharynx
tonsil
hsv
also
may
produc
pharyng
erythema
exud
time
indistinguish
strep
throat
lesion
may
extend
palat
gingiva
tongu
lip
face
gener
symptom
includ
fever
malais
inabl
eat
cervic
lymphadenopathi
treatment
hsv
oral
infect
antiherpet
medic
efficaci
reduc
durat
sign
symptom
well
viral
shed
acyclovir
valcyclovir
famciclovir
use
treat
hsv
infect
acetaminophen
nonsteroid
antiinflammatori
drug
effect
analges
antipyret
treatment
start
soon
symptom
develop
use
viral
bacteri
diseas
oral
hydrat
gargl
salt
water
may
help
allevi
pharyng
complaint
oral
cough
suppress
decongest
antihistamin
help
depend
symptom
present
lozeng
contain
local
anesthet
wide
avail
counter
seem
provid
temporari
relief
sore
throat
sever
author
report
adjuv
therapi
dexamethason
decreas
durat
throat
pain
patient
sever
odynophagia
regimen
use
magnitud
effect
vari
among
studi
advers
effect
report
durat
followup
often
limit
one
random
doubleblind
placebocontrol
trial
adjuv
dexamethason
therapi
children
found
efficaci
patient
radtposit
pharyng
benefit
judg
margin
clinic
import
author
recommend
use
corticosteroid
therapi
ga
pharyng
acut
epiglott
supraglott
inflammatori
process
epiglotti
adjac
structur
lead
lifethreaten
acut
respiratori
obstruct
past
epiglott
occur
frequent
children
year
age
associ
mainli
haemophilu
influenza
type
b
hib
infect
sinc
initi
childhood
vaccin
program
epiglott
caus
organ
much
less
common
nevertheless
still
case
hib
epiglott
immun
nonimmun
children
possibl
infect
pathogen
exclud
complet
vaccin
patient
bacteria
associ
epiglott
nowaday
includ
streptococcu
pneumonia
staphylococcu
aureu
beta
hemolyt
streptococci
multipl
agent
includ
bacteria
virus
fungi
implic
rare
case
typic
present
children
includ
fever
irrit
sore
throat
rapidli
progress
stridor
respiratori
distress
affect
child
adopt
forwardlean
posit
drool
oral
secret
tri
breath
adult
usual
present
sore
throat
milder
diseas
although
airway
compromis
occur
also
physic
examin
patient
suspect
epiglott
requir
care
inspect
oropharyng
suprapharyng
area
diagnosi
requir
direct
visual
erythemat
swollen
epiglotti
laryngoscopi
risk
airway
obstruct
procedur
perform
children
skill
personnel
equip
secur
airway
avail
airway
secur
cultur
surfac
epiglotti
along
blood
cultur
obtain
guid
antibiot
therapi
manag
focus
two
import
aspect
close
monitor
airway
intub
necessari
treatment
intraven
antibiot
aforement
possibl
failur
vaccin
antibiot
direct
hib
everi
patient
regardless
immun
statu
cefotaxim
ceftriaxon
ampicillinsulbactam
appropri
choic
steroid
use
commonli
manag
acut
epiglott
although
random
trial
done
support
practic
case
hib
epiglott
diagnos
american
academi
pediatr
recommend
postexposur
prophylaxi
rifampin
given
household
contact
least
one
child
household
younger
year
age
child
household
younger
month
age
receiv
primari
seri
hib
vaccin
immunosuppress
child
regardless
child
hib
immun
statu
acut
pharyng
extrem
common
disord
usual
run
benign
cours
almost
case
primari
care
physician
must
discrimin
viral
sore
throat
requir
symptomat
manag
ga
pharyng
requir
specif
antimicrobi
therapi
distinct
import
ga
pharyng
treat
appropri
minim
risk
suppur
nonsuppur
complic
equal
import
minim
unnecessari
potenti
deleteri
overtreat
viral
infect
antimicrobi
agent
articl
outlin
epidemiolog
clinic
laboratori
find
assist
decis
make
clinician
also
must
alert
occurr
rare
seriou
upper
respiratori
infect
may
life
threaten
requir
special
form
therapi
eg
diphtheria
parapharyng
suppur
process
acut
epiglott
